Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Targets › NR2E3

NR2E3 (1 companies · 2 programs)

Companies with an active program directed at NR2E3.

Ocugen, Inc. OCGN

  • OCU400 — Retinitis Pigmentosa Phase 3
  • OCU400 — Leber Congenital Amaurosis Phase 3